Literature DB >> 24258072

Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry.

Wulfran Bougouin1, Eloi Marijon, Etienne Puymirat, Pascal Defaye, David S Celermajer, Jean-Yves Le Heuzey, Serge Boveda, Salem Kacet, Philippe Mabo, Claude Barnay, Antoine Da Costa, Jean-Claude Deharo, Jean-Claude Daubert, Jean Ferrières, Tabassome Simon, Nicolas Danchin.   

Abstract

AIMS: Limited data are available on long-term prognosis or causes-of-death analysis among survivors of acute myocardial infarction (MI) according to whether or not they developed ventricular fibrillation (VF) during the acute stage of MI. METHODS AND
RESULTS: Among 3670 MI patients hospitalized in France in 2005 and enrolled in this prospective follow-up cohort study, we assessed in-hospital mortality and 5-year cause of death among those who survived to hospital discharge, according to whether they developed VF (116 cases) or not, during the acute stage. 94.5% of patients had complete follow-up at 5 years. In-hospital mortality was significantly higher among VF patients (adjusted OR 7.38, 95% CI 4.27-12.75, P < 0.001). Among 3463 survivors at hospital discharge, 1024 died during a mean follow-up of 52 ± 2 months. The overall survival rate at 5 years was 74.4% (95% CI 72.8-76.0). In Cox multivariate analysis, occurrence of VF during the acute phase of MI was not associated with an increased mortality at 5 years (HR 0.78, 95% CI 0.38-1.58, P = 0.21). The distribution of causes of death at 5 years did not statistically differ according to the presence or absence of VF, especially for sudden cardiac death (13.1% in VF group vs.12.9% in non-VF group), despite a very low rate of implantation of cardioverter defibrillator in both groups (Overall rate 1.2%).
CONCLUSION: Patients developing VF in the setting of acute MI are at higher risk of in-hospital mortality. However, VF is not associated with a higher long-term all-cause or sudden cardiac death mortality.

Entities:  

Keywords:  Acute coronary syndrome; Implantable cardioverter defibrillator; Prognosis; Sudden death; Ventricular fibrillation

Mesh:

Year:  2013        PMID: 24258072     DOI: 10.1093/eurheartj/eht453

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

1.  Warning Symptoms Are Associated With Survival From Sudden Cardiac Arrest.

Authors:  Eloi Marijon; Audrey Uy-Evanado; Florence Dumas; Nicole Karam; Kyndaron Reinier; Carmen Teodorescu; Kumar Narayanan; Karen Gunson; Jonathan Jui; Xavier Jouven; Sumeet S Chugh
Journal:  Ann Intern Med       Date:  2016-12-22       Impact factor: 25.391

2.  Antiarrhythmic effects of interleukin 1 inhibition after myocardial infarction.

Authors:  Nicole M De Jesus; Lianguo Wang; Johnny Lai; Robert R Rigor; Samantha D Francis Stuart; Donald M Bers; Merry L Lindsey; Crystal M Ripplinger
Journal:  Heart Rhythm       Date:  2017-01-19       Impact factor: 6.343

Review 3.  Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors.

Authors:  Sumra Komal; Nimrah Komal; Ali Mujtaba; Shu-Hui Wang; Li-Rong Zhang; Sheng-Na Han
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

4.  The Particular Expression Profiles of Circular RNA in Peripheral Blood of Myocardial Infarction Patients by RNA Sequencing.

Authors:  Qi Li; Yuanyong Wang; Yi An; Jianxun Wang; Yufang Gao
Journal:  Front Cardiovasc Med       Date:  2022-06-06

5.  For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death.

Authors:  Ivaylo Tonchev; David Luria; David Orenstein; Chaim Lotan; Yitschak Biton
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931

6.  The autonomic nervous system and ventricular arrhythmias in myocardial infarction and heart failure.

Authors:  Perry Wu; Marmar Vaseghi
Journal:  Pacing Clin Electrophysiol       Date:  2020-02-05       Impact factor: 1.976

7.  Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.

Authors:  Reza Jabbari; Thomas Engstrøm; Charlotte Glinge; Bjarke Risgaard; Javad Jabbari; Bo Gregers Winkel; Christian Juhl Terkelsen; Hans-Henrik Tilsted; Lisette Okkels Jensen; Mikkel Hougaard; Stephanie E Chiuve; Frants Pedersen; Jesper Hastrup Svendsen; Stig Haunsø; Christine M Albert; Jacob Tfelt-Hansen
Journal:  J Am Heart Assoc       Date:  2015-01-05       Impact factor: 5.501

Review 8.  Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction.

Authors:  Charlotte Glinge; Stefan Sattler; Reza Jabbari; Jacob Tfelt-Hansen
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

9.  Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction.

Authors:  Reza Jabbari; Javad Jabbari; Charlotte Glinge; Bjarke Risgaard; Stefan Sattler; Bo Gregers Winkel; Christian Juhl Terkelsen; Hans-Henrik Tilsted; Lisette Okkels Jensen; Mikkel Hougaard; Stig Haunsø; Thomas Engstrøm; Christine M Albert; Jacob Tfelt-Hansen
Journal:  BMC Med Genet       Date:  2017-11-21       Impact factor: 2.103

10.  Taurine Alleviates Sympathetic Innervation by Inhibiting NLRP3 Inflammasome in Postinfarcted Rats.

Authors:  Cheng-Che Lee; Wei-Ting Chen; Syue-Yi Chen; Tsung-Ming Lee
Journal:  J Cardiovasc Pharmacol       Date:  2021-04-15       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.